BioCryst Pharmaceuticals Inc (BCRX) — Free Cash Flow Generation Index

Latest as of December 2025: 1.00x

BioCryst Pharmaceuticals Inc (BCRX) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $275.23 Million represents 1% of operating cash flow ($276.04 Million). Read BioCryst Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

$275.23 Million

USD

Operating Cash Flow

$276.04 Million

USD

Capital Expenditures

$802.00K

USD

BioCryst Pharmaceuticals Inc Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for BioCryst Pharmaceuticals Inc across 1 annual periods. Explore BioCryst Pharmaceuticals Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for BioCryst Pharmaceuticals Inc (2025–2025)

Year-by-year Free Cash Flow Generation Index for BioCryst Pharmaceuticals Inc. For the full company profile including market capitalisation, see BCRX market cap.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2025	0.99x	$327.41 Million	$329.88 Million	$2.47 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).